Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3305)
All Articles published online
|
Oct 21, 2006 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shimizu T, Yokomuro S, Mizuguchi Y, Kawahigashi Y, Arima Y, Taniai N, Mamada Y, Yoshida H, Akimaru K, Tajiri T. Effect of transforming growth factor-β1 on human intrahepatic cholangiocarcinoma cell growth. World J Gastroenterol 2006; 12(39): 6316-6324 [PMID: 17072955 DOI: 10.3748/wjg.v12.i39.6316] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i39/6316.htm |
| Number | Citing Articles |
| 1 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 605 doi: 10.1007/978-3-319-26956-6_31
|
| 2 |
Hidenori Ojima. Clinicopathological significance of growth factors and their receptors as potential therapeutic targets for biliary tract carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2012; 19(4): 319 doi: 10.1007/s00534-011-0497-z
|
| 3 |
Nicola F. Fletcher, Elizabeth Humphreys, Elliott Jennings, William Osburn, Samantha Lissauer, Garrick K. Wilson, Sven C. D. van IJzendoorn, Thomas F. Baumert, Peter Balfe, Simon Afford, Jane A. McKeating. Hepatitis C virus infection of cholangiocarcinoma cell lines.
Journal of General Virology
2015; 96(6): 1380 doi: 10.1099/vir.0.000090
|
| 4 |
Chutamas Thepmalee, Aussara Panya, Mutita Junking, Thaweesak Chieochansin, Pa-thai Yenchitsomanus. Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells. Human Vaccines & Immunotherapeutics 2018; 14(6): 1423 doi: 10.1080/21645515.2018.1431598
|
| 5 |
Ismaïl Hendaoui, Ahlem Lahmar, Luca Campo, Sihem Mebarki, Sandrine Bichet, Daniel Hess, Martin Degen, Nidhameddine Kchir, Leila Charrada-Ben Farhat, Rania Hefaiedh, Christian Ruiz, Luigi M. Terracciano, Richard P. Tucker, Lotfi Hendaoui, Ruth Chiquet-Ehrismann. Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.630139
|
| 6 |
Takuji Okusaka, Hidenori Ojima, Chigusa Morizane, Masafumi Ikeda, Tatsuhiro Shibata. Emerging drugs for biliary cancer. Expert Opinion on Emerging Drugs 2014; 19(1): 11 doi: 10.1517/14728214.2014.870553
|
| 7 |
Miguel Á. Manzanares, Akihiro Usui, Deanna J. Campbell, Catherine I. Dumur, Gabrielle T. Maldonado, Michel Fausther, Jonathan A. Dranoff, Alphonse E. Sirica. Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model. The American Journal of Pathology 2017; 187(5): 1068 doi: 10.1016/j.ajpath.2017.01.013
|
| 8 |
Panagiotis Papoutsoglou, Corentin Louis, Cédric Coulouarn. Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma. Cells 2019; 8(9): 960 doi: 10.3390/cells8090960
|
| 9 |
Junichi Shoda, Kazunori Ishige, Hiroaki Sugiyama, Toru Kawamoto. Biliary tract carcinoma: clinical perspectives on molecular targeting strategies for therapeutic options. Journal of Hepato-Biliary-Pancreatic Sciences 2012; 19(4): 342 doi: 10.1007/s00534-012-0520-z
|
| 10 |
Riccardo Carloni, Alessandro Rizzo, Angela Dalia Ricci, Alessandro Di Federico, Raffaele De Luca, Deniz Can Guven, Suayib Yalcin, Giovanni Brandi. Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine. Translational Oncology 2022; 25: 101514 doi: 10.1016/j.tranon.2022.101514
|
| 11 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_31-1
|
| 12 |
SUNG RYOL LEE, JAE WOOK SHIN, HYUNG OOK KIM, BYUNG HO SON, CHANG HAK YOO, JUN HO SHIN. Determining the effect of transforming growth factor-β1 on cdk4 and p27 in gastric cancer and cholangiocarcinoma. Oncology Letters 2013; 5(2): 694 doi: 10.3892/ol.2012.1024
|
| 13 |
Ling Liu, Nianfeng Li, Qi Zhang, Jixiang Zhou, Ling Lin, Xinxin He. Inhibition of ERK1/2 Signaling Impairs the Promoting Effects of TGF-β1 on Hepatocellular Carcinoma Cell Invasion and Epithelial‐Mesenchymal Transition. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2017; 25(9): 1607 doi: 10.3727/096504017X14938093512742
|
| 14 |
Caterina Peraldo-Neia, Giuliana Cavalloni, Marco Soster, Loretta Gammaitoni, Serena Marchiò, Francesco Sassi, Livio Trusolino, Andrea Bertotti, Enzo Medico, Lorenzo Capussotti, Massimo Aglietta, Francesco Leone. Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-918
|